1. Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
   Lívia da Cunha Agostini et al, 2024, European Journal of Pharmacology CrossRef
2. The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial
   Rafael B. R. León-Cachón et al, 2020, Scientific Reports CrossRef
3. Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial
   Magdalena Gómez-Silva et al, 2019, Scientific Reports CrossRef